Nordwest-Krankenhaus Sanderbusch
About Nordwest-Krankenhaus Sanderbusch
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
1
Tetec AG
1
University Hospital, Essen
1
University of Ulm
1
Clinical Trials at Nordwest-Krankenhaus Sanderbusch
During the past decade, Nordwest-Krankenhaus Sanderbusch conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
2010-07-01
Recruiting
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA
2015-07-01
2022-04-01
Completed
10,044
Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
2015-12-01
2019-05-01
Completed
245
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nordwest-Krankenhaus Sanderbusch"
#1 collaborator was "Aesculap AG" with 1 trials as a collaborator and "Winicker Norimed GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Nordwest-Krankenhaus Sanderbusch
According to Clinical.Site data, the most researched conditions in "Nordwest-Krankenhaus Sanderbusch" are
"Acute Myeloid Leukemia (AML)" (1 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Cartilage Disease" (1 trials), "Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)" (1 trials) and "Secondary Prevention" (1 trials). Many other conditions were trialed in "Nordwest-Krankenhaus Sanderbusch" in a lesser frequency.
Clinical Trials Intervention Types at Nordwest-Krankenhaus Sanderbusch
Most popular intervention types in "Nordwest-Krankenhaus Sanderbusch" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "ASA 100 mg" (1 trials), "dabigatran etexilate" (1 trials), "optional ASA as comedication" (1 trials), "placebo to ASA" (1 trials) and "placebo to dabigatran etexilate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nordwest-Krankenhaus Sanderbusch
The vast majority of trials in "Nordwest-Krankenhaus Sanderbusch" are
4 trials for "All" genders.
Clinical Trials Status at Nordwest-Krankenhaus Sanderbusch
Currently, there are NaN active trials in "Nordwest-Krankenhaus Sanderbusch".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nordwest-Krankenhaus Sanderbusch,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nordwest-Krankenhaus Sanderbusch, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".